Delivery Order SPE2DB24D2018-SPE2DB25FWVV9
- Not listed
- The Defense Logistics Agency awarded a $6.76K delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg/8.19 mg tablets, quantity 40) with a completion date of July 31, 2025. This is a firm fixed-price, non-set-aside contract issued on July 10, 2025, with performance to be fulfilled at the contractor's Conshohocken, Pennsylvania location. LONSURF is a prescription oncology medication used in cancer treatment, reflecting the Defense Logistics Agency's ongoing pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $6.76K to AmerisourceBergen Drug Corp for the supply of LONSURF 20 mg–8.19 mg tablets (40-count packages). This non-competitive, firm fixed-price delivery order was issued on June 16, 2025, with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LONSURF is a combination chemotherapy medication used in cancer treatment, reflecting the breadth of...
- The Defense Logistics Agency awarded a $30,519.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, 60-count packages) on September 22, 2025, with an ultimate completion date of October 14, 2025. This delivery order was awarded competitively without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,539.15 to AmerisourceBergen Drug Corp for LONSURF 15 mg-6.14 mg tablets (20-count units) on September 25, 2025, with an ultimate completion date of October 17, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the place of performance for this delivery order, which represents a single transaction under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,124.17 to AmerisourceBergen Drug Corp for LONSURF 15 mg-6.14 mg tablets (40-count package), with an ultimate completion date of October 7, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating open competition. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and distribution...
- The Defense Logistics Agency awarded a delivery order valued at $10,224.47 to AmerisourceBergen Drug Corp for LONSURF (15 mg-6.14 mg tablets, 60-count supply) with an ultimate completion date of September 29, 2025. This is a firm fixed-price, non-set-aside contract utilizing a competitive award process. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LONSURF (TAS-102) 20 mg-8.19 mg tablets in a quantity of 40 units, valued at $6,760.14 under a firm fixed price contract. This award, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation and represents a competitive delivery order. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LONSURF is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of LONSURF (20 mg-8.19 mg tablets, 60-count packages) with a ceiling value of $10,173.33. This competitively awarded, non-set-aside contract is scheduled for completion by September 30, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $13,520.28 to AmerisourceBergen Drug Corp for the supply of LONSURF (20 mg-8.19 mg tablets) in quantities of 40 units. This competitive award, issued on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVV9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,078.30 to AmerisourceBergen Drug Corp for the supply of LONSURF (15 mg-6.14 mg tablets, quantity 20) with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. LONSURF is an FDA-approved combination chemotherapy medication used in oncology treatment, reflecting the Defense Logistics Agency's continued procurement of specialized pharmaceutical products for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical prime vendor vehicle enables the contractor to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded federal contracts across multiple therapeutic domains demonstrates its established capability as a critical supplier within the federal medical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 7/28/25 |